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Loss of Collagen VII Is Associated with Reduced
Transglutaminase 2 Abundance and Activity
Victoria Ku¨ttner1,2,3,5, Claudia Mack1,5, Christine Gretzmeier1,2,3, Leena Bruckner-Tuderman1,2,3,4 and
Jo¨rn Dengjel1,2,3,4
Absence of collagen VII leads to widespread cellular and tissue phenotypes. However, the underlying molecular
mechanisms are not well understood. To gain insights into cellular responses to loss of collagen VII, we
undertook a quantitative disease proteomics approach. By using recessive dystrophic epidermolysis bullosa
(RDEB), a skin blistering disease caused by collagen VII deficiency, as a genetic model, collagen VII–dependent
differences in cellular protein abundances and protein–protein interactions were analyzed. Absence of collagen
VII led to alterations of intracellular protein compositions and to perturbations in cell adhesion, protein
trafficking, and the turnover pathway autophagy. A potential linker of the different cellular phenotypes is
transglutaminase 2 (TGM2), a multifunctional enzyme important for protein cross-linking. TGM2 was identified as
a stable interaction partner of collagen VII. In RDEB, both abundance and activity of TGM2 were reduced,
accounting not only for diminished adhesion and perturbed autophagy but also for reduced cross-linking of the
extracellular matrix and for decreased epidermal–dermal integrity in RDEB.
Journal of Investigative Dermatology (2014) 134, 2381–2389; doi:10.1038/jid.2014.185; published online 15 May 2014
INTRODUCTION
Collagen VII is a secreted triple-helical protein produced by
both epidermal keratinocytes and dermal fibroblasts. It is
the main component of anchoring fibrils and mediates the
attachment of basal keratinocytes to the underlying dermis
via binding to laminin 332 (Nystrom et al., 2013a). The
maintenance of epidermal–dermal adhesion has been thought
to be the central property of collagen VII. However, clinical
observations and recent laboratory investigations suggest
broader functions. In patients, functional loss of collagen VII
leads to multiple phenotypes beside dermal–epidermal
detachment, e.g., scarring, fibrosis, and higher susceptibility
to skin cancer (Fritsch et al., 2008; Martins et al., 2009).
Recent mouse studies showed that collagen VII regulates
wound healing by a dual mechanism; it targets both re-
epithelialization and maturation of the granulation tissue
(Nystrom et al., 2013b). In vitro loss of collagen VII in
dermal fibroblasts is also associated with higher abundance
of interstitial extracellular matrix (ECM) proteins, diminished
deposition of basement membrane proteins, and altered post-
translational modifications (Fritsch et al., 2008; Kuttner et al.,
2013).
Severe generalized recessive dystrophic epidermolysis bul-
losa (RDEB), a congenital disorder caused by null mutations
in the collagen VII gene, COL7A1, demonstrates the vital
importance of collagen VII and the widespread, devastating
consequences of its loss. The patients suffer from trauma-
induced generalized skin blistering and healing with scarring.
With time, incessant wounding, slow healing, and subsequent
scarring induce a pro-fibrotic environment in the skin, which
supports the development of squamous cell carcinoma (Fine
et al., 2009). Consequently, it has been suggested that RDEB
fibroblasts have a similar role as cancer-associated fibroblasts
(Ng et al., 2012).
To determine how loss of collagen VII affects the cellular
phenotype of dermal fibroblasts, we used unbiased quantita-
tive mass spectrometry (MS)–based proteomic analyses of
RDEB and control fibroblasts. The aim was to detect deregu-
lated collagen VII–dependent intracellular protein networks
and pathways. We observed inter alia perturbations of auto-
phagy, a cellular stress response, which is involved in the
turnover of proteins and organelles by lysosomal degradation.
To identify the underlying molecular mechanisms, SILAC-
based (stable isotope labeling by amino acids in cell culture)
analyses of affinity-purified collagen VII complexes were used.
Stable and transient binding partners of collagen VII in
dermal fibroblasts were determined. Tissue transglutaminase
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(transglutaminase 2, TGM2), a multifunctional enzyme that
mediates protein cross-linking, was uncovered as a stable
interaction partner of collagen VII and its influence on RDEB
disease phenotypes was further elucidated.
RESULTS
Phenotypic characteristics of collagen VII–deficient fibroblasts
Loss of collagen VII has widespread structural and functional
consequences on cellular proteomes (Kuttner et al., 2013;
Nystrom et al., 2013b). To identify possible collagen
VII–dependent cellular phenotypes, we compared primary
collagen VII–deficient RDEB fibroblasts with control cells
(Supplementary Figure S1a online; Supplementary Table S1
online). RDEB fibroblasts detached faster and to a higher
extent from cell culture plates compared with control fibro-
blasts, indicating reduced cell adhesion due to loss of collagen
VII (Figure 1a).
It has been shown that loss of collagen VI can lead to an
impairment of autophagy (Grumati et al., 2010). Hence, we
tested the autophagic capacity of RDEB fibroblasts. Western
blot and immunofluorescence analysis of the autophagosomal
marker LC3-II showed higher abundance of autophagosomes
in RDEB fibroblasts under unperturbed conditions (Figure 1b;
Supplementary Figure S1b online). Treatment with concana-
mycin A, which blocks lysosomal ATPases and thereby
degradation of autophagosomes, led to a comparable accu-
mulation of autophagosomes in control and RDEB fibroblasts.
Hence, the autophagic capacity was lower in the absence of
collagen VII (Figure 1b, right panel). To test whether this effect
was collagen VII dependent, we generated doxycycline-
inducible COL7A1 shRNA knockdown fibroblasts and eval-
uated the autophagic flux. After 6 days of doxycycline treat-
ment, collagen VII mRNA and protein abundance were
decreased to 40 and 20%, respectively (Figure 1c and d).
Indeed, the autophagic flux was lower in COL7A1 knockdown
compared with vector control cells, demonstrating that lower
abundance of collagen VII accounts for reduced autophagic
flux (Figure 1e).
Intracellular proteome alterations in collagen VII–deficient
fibroblasts
To identify intracellular target proteins, which may account
for the above phenotypes in RDEB cells, we performed an
unbiased quantitative proteomic investigation. Skin fibroblasts
derived from four collagen VII–deficient RDEB patients and
from three controls (Supplementary Table S1 online), all with
the same passage number, were SILAC labeled and the
intracellular proteomes were analyzed. To compare all pro-
teomes with each other, a ‘‘light’’-labeled control SILAC-mix
was spiked into all labeled samples (Figure 2a) (Geiger et al.,
2010). In two biological replicates for each condition, 2,048
proteins were reproducibly quantified (Supplementary Table
S2 online). To identify significantly regulated proteins, we
performed an analysis of variance test between all RDEB and
control samples. This resulted in 134 and 157 significantly up-
and downregulated proteins in RDEB fibroblasts, respectively
(Pp0.05, Benjamini Hochberg-corrected) (Supplementary
Table S2 online). Regulated proteins were further analyzed
using DAVID (Huang da et al., 2009) to detect enrichment of
functional protein classes. Proteins carrying the gene ontology
terms ‘‘ECM part’’, ‘‘vesicle-mediated transport’’, and
‘‘response to starvation’’ were upregulated in all RDEB
samples (Supplementary Figure S2a online; Figure 2b). The
latter two may reflect the observed accumulation of autopha-
gosomes (Figure 1b; Supplementary Figure S1b online). On
the other hand, proteins with the gene ontology terms ‘‘plasma
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Figure 1. Reduced adhesion and autophagic flux in collagen VII–deficient fibroblasts. (a) Cell adhesion is reduced in recessive dystrophic epidermolysis bullosa
(RDEB) fibroblasts. Number of adherent cells was measured after treatment with 0.25% trypsin for indicated time points. (b) Autophagosomes accumulate in RDEB
fibroblasts, as analyzed by western blot against the autophagosomal marker LC3-II. LC3-II flux, as a measure for autophagic capacity, was determined by
quantification of LC3-II signal with and without concanamycin A (C-A) treatment (mean±SD, ***Pp0.001). (c) Inducible collagen VII small hairpin RNA (shRNA)
knockdowns. Messenger RNA (mRNA) expression is reduced up to 60% (mean±SEM, n¼3, *Pp0.05) and protein expression (d) up to 80%. Black bars indicate
quantification by densitometry. (e) Western blot against LC3 shows accumulation of autophagosomes in collagen VII shRNA knockdown fibroblasts.
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membrane part’’, ‘‘DNA-dependent DNA replication’’,
and ‘‘cell adhesion’’ were downregulated (enrichment score
X1.0; Pp0.05, Benjamini Hochberg-corrected) (Figure 2b;
Supplementary Figure S2a online). The reduced abundance of
adhesion proteins such as intercellular adhesion molecule 1,
laminin subunit alpha-4, and laminin subunit beta-2 could
account for the reduced adhesion of RDEB cells (Figure 1a).
In a previous study, we showed that loss of collagen VII
leads to global alterations of the cellular microenvironment
(Kuttner et al., 2013). To test whether protein secretion or
incorporation into the ECM is affected in RDEB, we compared
intra- and extracellular protein abundances (Supplementary
Figure S2b online). Intracellular protein abundances correlated
reasonably well with protein abundances detected in condi-
tioned medium. Protein abundances in the ECM, however,
exhibited larger deviations from intracellular values, indicating
that loss of collagen VII perturbs ECM assembly rather than
protein secretion.
Identification of collagen VII interaction partners
The global proteomics analyses identified target proteins that
may account for the observed phenotypes in RDEB cells.
However, the experimental setup did not allow to discriminate
between direct effects due to the loss of collagen VII and
secondary downstream effects.
To analyze how the observed proteomic changes and
disease phenotypes are associated with the loss of collagen
VII, we determined the binding partners of collagen VII in skin
fibroblasts. For this purpose, a SILAC-based quantitative MS
analysis of immunoaffinity-purified (IP) collagen VII com-
plexes was used (Figure 3a; Supplementary Figure S3 online)
(Kuttner et al., 2013). Collagen VII complexes were purified
from control fibroblasts, and collagen VII–deficient RDEB cells
served as negative controls to identify unspecifically bound
proteins. The experimental design of the IPs allowed discri-
mination between stable and transient interaction partners,
depending on whether the samples were mixed before or after
the IP step (Figure 3a). Comparison of the SILAC ratios of
combined and separate IPs discriminated stable collagen VII
interaction partners (red) from transient (green) and unspecific
(blue) ones (Figure 3b). The stable interaction partners dis-
played a greater twofold enrichment in both the separate and
the combined IPs, whereas the transient interaction partners
were significantly enriched only in the separate IPs. A list of all
identified proteins and respective abundance ratios can be
found in the Supplementary Table S3 online. Transient
interactors of collagen VII were found to be myosins, actin-
binding proteins, and proteins involved in adhesion and
vesicle transport (Figure 3c). Four stable interaction partners
of collagen VII were identified (Figure 3c). The collagen-
modifying enzymes lysyl hydroxylase 3 (PLOD3) and hydro-
xylysine galactosyltransferase 1 (GLT25D1) catalyze hydro-
xylation and subsequent galactosylation of lysine residues in
the Gly-X-Lys repeats of collagens, respectively (Schegg et al.,
2009). Also, the transcription factor nuclear factor I/C was
identified as a stable interactor of collagen VII. Finally, TGM2,
which has been shown to be involved in collagen VII/
anchoring fibril cross-linking (Raghunath et al., 1996), was
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Figure 2. Global proteome analysis of collagen VII–deficient fibroblasts.
(a) Quantitative SILAC (stable isotope labeling by amino acids in cell culture)-
based workflow. Medium and heavy SILAC-labeled cells were mixed with a
light-labeled standard 1:1:1 and samples were processed as outlined. (b) Fold
changes of selected significantly up- and downregulated proteins
corresponding to the indicated gene ontology terms. ECM, extracellular matrix;
MCM, minichromosome-maintaining complex.
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identified as a stable binding partner, and the interaction was
confirmed by western blot (Figure 3d).
Reduced TGM2 expression in collagen VII–negative fibroblasts
As TGM2 is a stable interaction partner of collagen VII and a
regulator of autophagy (Nurminskaya and Belkin, 2012; Wang
and Griffin, 2012), it is a likely candidate to influence several
of the observed phenotypes associated with collagen VII
deficiency. Therefore, we focused the further analyses on the
collagen VII–dependent regulation of TGM2. In RDEB fibro-
blasts, TGM2 mRNA levels and protein abundance were
reduced as compared with control fibroblasts (Figure 4a–c).
This was validated by immunofluorescence staining of the
fibroblasts (Figure 4d). To determine whether extracellular
collagen VII could rescue TGM2 expression, RDEB fibroblasts
were grown for 12 hours on partially purified recombinant
collagen VII or a control substrate. TGM2 immunofluores-
cence signal was stronger in RDEB fibroblasts grown on
recombinant collagen VII, indicating dependence of TGM2
expression on the presence of collagen VII in the ECM
(Figure 4e).
Reduced TGM2 activity in RDEB
TGM2 is a highly regulated enzyme. Its cross-linking activity
can be controlled on the level of gene expression, localization
of protein, presence of cofactors, and redox state (Collighan
and Griffin, 2009). We analyzed the cross-linking activity by
measuring the incorporation of pentylamine biotin (PAB) in
cells. PAB is an artificial biotinylated TGM2 substrate that can
be covalently bound to target proteins by TGM2 (Deasey
et al., 2013). Following cell lysis and western blot, biotiny-
lated proteins can be detected with streptavidin-horseradish
peroxidase. As fibroblasts naturally contain streptavidin-
binding proteins, each sample was compared with lysates
of cells, which were not incubated with PAB. In the presence
of PAB, one specific band with a molecular weight of
4250 kDa was detected, which probably represents fibro-
nectin, a major substrate of TGM2 (Figure 5a). Incorporation
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NC2-10 (upper panel) and anti-TGM2 antibody (lower panel), respectively. An enrichment of collagen VII and TGM2 can be observed. IgG is the isotype control.
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of PAB was clearly reduced in RDEB fibroblasts (Figure 5a,
right panel).
Knowing that TGM2 activity was reduced in RDEB fibro-
blasts in vitro, we investigated whether TGM2 activity was
also affected in RDEB skin. Different types of transglutami-
nases are active in human skin; TGM1, TGM3, and TGM5 are
expressed in the spinous and granular layers of the epidermis,
whereas TGM2 is expressed in dermal fibroblasts and is
active at the basement membrane zone and in the dermis
(Raghunath et al., 1998). For the determination of TGM
activity, cryosections of normal and RDEB skin specimens
were incubated with biotin-cadaverine, a transglutaminase
substrate that binds to the active site of transglutamninases in
the presence of calcium. In normal skin, biotin-cadaverine
stained the upper layers of the epidermis, the basement
membrane zone, as well as the dermal compartment. In
RDEB skin, the intensity of the staining in the upper layers
of the epidermis was comparable to controls. In contrast, the
staining in the basement membrane zone and the dermis
was clearly reduced (Figure 5b). Furthermore, e-g-glutamyl-
lysine cross-links, which are catalyzed by TGM2 were less
abundant in the dermis of RDEB skin (Figure 5c). Taken
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together, absence of collagen VII in RDEB led to reduced
abundance and activity of TGM2 and altered the architecture
of the ECM.
DISCUSSION
We used collagen VII–deficient RDEB cells as a genetic model
to study the different cellular phenotypes associated with loss
of collagen VII. By focusing on the intracellular proteome, we
aimed at directly linking collagen VII deficiency to cellular
responses. Functional deficiency of collagen VII in RDEB
led to significant abundance changes of 291 proteins that
belong to well-defined protein groups. Increased levels of
intracellular tenascin-C, collagen III, collagen VI, collagen XII,
and transforming growth factor-beta-induced protein ig-h3
were detected in RDEB fibroblasts. These proteins were also
increased in the microenvironment of RDEB cells, indicating a
general accumulation of ECM proteins and a potential regula-
tion at the transcriptional level (Kuttner et al., 2013).
Transcriptional upregulation of the expression of some ECM
proteins, inter alia collagen XII in RDEB was recently reported
(Ng et al., 2012). Most of the aforementioned proteins are
targets of transforming growth factor-b signaling (Verrecchia
et al., 2001), suggesting that transforming growth factor-b
drives ECM production in RDEB as in other fibrotic conditions.
Comparison of the extra- and intracellular proteomes
highlighted alterations between the different compartments.
The effects of loss of collagen VII were more evident in the
microenvironment than inside the cell and its loss appeared to
perturb ECM assembly. Hence, in order to gain meaningful
information it is critical to directly study the perturbed
compartment.
It has been postulated that RDEB fibroblasts attach less
firmly than control cells to cell culture plates and that
complete re-expression of COL7A1 restores the normal adhe-
sion phenotype (Chen et al., 2002). This suggested that loss of
collagen VII has global implications on the adhesion
machinery. Indeed, we found reduced abundance of cell
adhesion proteins such as ICAM1, laminins, and certain
integrins. These findings indicate that the less adhesive
phenotype of RDEB fibroblasts may not depend only on the
absence of collagen VII but also on the reduced abundance of
other cell adhesion proteins.
Loss of collagen VII also had profound implications on the
composition of the intracellular proteome. For example,
‘‘vesicular transport’’ was identified as perturbed. The vesicu-
lar carriers, COPI and COPII, which facilitate the endoplasmic
reticulum-Golgi retrograde and anterograde transport, respec-
tively, were more abundant in RDEB fibroblasts. Small COP
vesicles measuring 80–90 nm have to increase in size to 200–
500 nm to allow transport of long rod-like collagen molecules
(Malhotra and Erlmann, 2011). It appears that in the fibrotic
setting in RDEB increased production of collagens results in
upregulation of respective vesicular coat proteins to ensure
proper transport and secretion.
Proteins involved in DNA replication such as components
of the minichromosome-maintaining complex were found
to be less abundant in RDEB cells. Minichromosome-
maintaining complex proteins assemble a helicase, which is
important for the initiation of the DNA replication fork and
cell proliferation (Forsburg, 2008; Nowinska and Dziegiel,
2010). The downregulation of these proteins might thus nega-
tively influence the proliferation of RDEB fibroblasts (Chen
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et al., 2002; Dumit et al., 2014). It has been suggested that
cells that produce elevated amounts of ECM proteins exhibit a
slower proliferation rate (Hetzel et al., 2005) in line with the
observations in the present study.
We also demonstrated that both collagen VII–deficient
RDEB and collagen VII knockdown fibroblasts exhibit reduced
autophagic flux. Autophagy is a cellular stress response, which
generally acts in a cytoprotective manner. The reduced
autophagic capacity in RDEB cells indicates an elevated stress
level in RDEB cells, and that the loss of an ECM protein
influences intracellular protein homeostasis. Reduced autop-
hagy and with it lysosomal degradation may also contribute
to the higher abundance of specific ECM proteins. This is in
agreement with the notion that reduced autophagy has been
identified in a number of fibrotic diseases (Del Principe et al.,
2013). However, the underlying signaling events appear to
be differentially regulated. In collagen VI–negative muscular
dystrophy, abnormally elevated Akt activity and increased
mTOR (mammalian target of rapamycin) activity were
observed (Grumati et al., 2010). This blocked induction of
autophagy, i.e., led to a reduction in LC3-II levels. In the
current study, autophagy appeared to be blocked at the
autophagosomal–lysosomal fusion stage, as LC3-II levels were
increased in RDEB cells compared with control cells.
Although knockdown of collagen VII was not complete, it
could reproduce LC3-II accumulation. Taken together, deregu-
lated autophagy can clearly be linked to fibrosis and perturba-
tions of the ECM. However, the molecular mechanisms appear
to be regulated in a cell-type and disease-specific manner and
need further investigations.
To link the observed, seemingly unrelated, phenotypic
changes and differences in the cellular proteome to the loss
of collagen VII, we quantitatively analyzed the collagen VII
interactome. SILAC-based MS identified stable and transient
interaction partners of collagen VII in dermal fibroblasts. The
collagen VII antibody that was used for the IP recognizes both
intracellular procollagen VII and extracellular mature collagen
VII (Bruckner-Tuderman et al., 1995). As we used cell lysates
of dermal fibroblasts, mostly intracellular proteins involved in
collagen VII trafficking and secretion were identified, but none
of the known extracellular interactors of collagen VII, e.g.,
collagen I, collagen IV, or fibronectin (Chen et al., 1997;
Villone et al., 2008). This might indicate that those interac-
tions occur only at tissue level and thus require a proper ECM
architecture, or that extracellular protein complexes are
heavily cross-linked and not solubilized with the methods
used here.
Transient interaction partners, vesicular and cytoskeletal
proteins, such as sorting nexin-18, nexilin, or unconventional
myosins I-e and I-c were identified, indicating that these
proteins have a role in collagen VII secretion. Lysyl hydro-
xylase 3 and hydroxylysine galactosyltransferase 1 were
identified as stable interaction partners. Both enzymes localize
mainly to the endoplasmic reticulum (Liefhebber et al., 2010)
and interact with collagen in the biosynthesis pathway. Also,
the transcription factor nuclear factor I/C, which has so far not
been linked to collagen VII, was identified as a stable inter-
action partner. Nuclear factor I/C is involved in the regulation
of various transforming growth factor-b1-dependent genes and
tooth development (Lee et al., 2011). In the skin, it is mainly
expressed by fibroblasts repressing gene expression in res-
ponse to transforming growth factor-b1 during wound healing
(Plasari et al., 2009). Further analyses have to be carried out
for full interpretation of this finding.
Perhaps the most intriguing discovery was that TGM2 is a
stable interaction partner of collagen VII in dermal fibroblasts
in vitro. This is in agreement with the finding that anchoring
fibrils in skin are targets of TGM2 (Raghunath et al., 1996).
TGM2 is a member of the transglutaminase superfamily,
which consists of nine members in humans: TGM1–7,
EPB42, and F13A1. TGM2 is a tightly regulated multifunc-
tional enzyme, which mediates the cross-linking of intra- and
extracellular proteins. However, depending on environmental
conditions such as calcium concentration and guanosine
triphosphate level, TGM2 may also display GTPase activity,
act as protein disulfide-isomerase, protein kinase, or adapter
protein (Nurminskaya and Belkin, 2012; Wang and Griffin,
2012). TGM2 was shown to be important for cell adhesion
(Telci and Griffin, 2006) and stabilization of extracellular
structures such as dermal microfibrils (Jensen et al., 2012), the
basement membrane laminin–nidogen complex (Aeschlimann
and Paulsson, 1991), and anchoring fibrils (Raghunath et al.,
1996). Interestingly, complete lack of TGM2 or its trans-
amidating activity have been shown to block autophagy
through inhibition of the fusion of autophagosomes and
lysosomes. As TGM2 cross-linking has an important role in
cytoskeletal organization, it is believed that cytoskeletal
disorganization in TGM2 / cells contributes to this
blockage (D’Eletto et al., 2009; Rossin et al., 2012; Budillon
et al., 2013). Hence, the fact that TGM2 expression and trans-
amidating cross-linking activity were significantly reduced in
RDEB fibroblasts and skin explains the reduced autophagic
capacity of these cells. Lack of TGM2 is also likely to be in
part causative for the perturbed ECM structures observed in
RDEB and, next to the absence of anchoring fibrils, one reason
for reduced dermal–epidermal adhesion and increased blister
formation. Expression of COL7A1 seems to be important for
TGM2 expression as its mRNA was downregulated in RDEB
fibroblasts. It has been shown that TGM2 also interacts with
integrins, e.g., integrin b1 (Caffarel et al., 2013). Interestingly,
we showed that loss of collagen VII leads to a downregulation
of several integrins in fibroblasts (Kuttner et al., 2013), among
them integrins a2 and b1. Thus, we hypothesize that through
the loss of collagen VII in RDEB directly and indirectly
interacting cell-surface receptors are downregulated. Together,
this may lead to two consequences for TGM2 expression and
protein abundance: (a) TGM2 expression is reduced through
perturbed integrin signaling and (b) TGM2 protein stability is
reduced through loss of binding partners. Both of these effects
may finally lead to the marked decrease in TGM2 protein
abundance observed in RDEB. An inducible knockdown of
collagen VII, which led to 80% reduction in dermal fibro-
blasts, did not reduce TGM2 protein level (Supplementary
Figure S1c online). This suggests that even reduced levels of
collagen VII are sufficient to maintain TGM2 protein abun-
dance and is in agreement with the observation that even
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partial restoration of collagen VII in an RDEB mouse model
led to improved skin integrity and resistance to mechanical
forces (Kern et al., 2009a).
Taken together, we identified regulated proteins as a
consequence of loss of collagen VII, as well as interaction
partners of collagen VII in dermal fibroblasts, highlighting the
strength of SILAC-based quantitative MS. Our findings link loss
of collagen VII in RDEB and observed phenotypes to deregu-
lated proteins downstream of collagen VII and uncover
molecular disease mechanisms. These represent the first steps
in designing causal therapies for this devastating disease.
MATERIALS AND METHODS
Patients and RDEB diagnosis
Skin specimens were obtained from four newborns with skin blister-
ing, but a negative family history for skin diseases. Immunofluores-
cence mapping revealed lack of collagen VII in the skin of all
patients. Mutation analysis of the collagen VII gene, COL7A1 (Kern
et al., 2006, 2009b) disclosed mutations leading to premature stop
codons and thus confirmed the diagnosis (Kuttner et al., 2013). The
clinical follow-up of the patients was carried out for 2.5–10 years at
the Epidermolysis Bullosa Center Freiburg. The study was approved
by the Ethics Committee of Freiburg University and conducted
according to the Declaration of Helsinki Principles. All specimens
were received with written, informed patient consent.
Cell culture and stable isotope labeling in cell culture
Primary dermal fibroblasts were isolated from the skin of the four
patients and, as controls, from the foreskin of circumcised 3, 4, and 9-
year-old healthy boys as described previously (Sprenger et al., 2013).
The cells were subcultured and passaged in SILAC-Dulbecco’s
modified Eagle’s medium (Thermo Fisher Scientific, Langenselbold,
Germany), supplemented with 10% dialyzed fetal bovine serum
(Gibco, Darmstadt, Germany), 1% Antibiotic-Antimycotic (100 ,
Invitrogen), 1% L-glutamine (PAN Biotech, Aidenbach, Germany),
42 mg l 1 L-arginine (Sigma-Aldrich, Taufkirchen, Germany),
73 mg l 1 L-lysine (Sigma-Aldrich), and 82 mg l 1 proline (Sigma-
Aldrich). According to the experimental setup, control or RDEB
fibroblasts were cultured and fully labeled for 2 weeks in the same
way but through incorporation of either L-arginine-13C6
14N4 and L-
lysine-2H4 (Arg6, Lys4; Sigma-Aldrich) or L-arginine-
13C6-
15N4 and L-
lysine-13C6
15N2 (Arg10 Lys8; Sigma-Aldrich).
Collagen VII immunoaffinity purification
Control and RDEB cells were completely labeled and 1 107 cells
were lysed in 1% Nonidet P-40, 0.1 M NaCl, 0.025 M Tris/HCl, pH 7.5
containing 1 mM Pefabloc (Merck, Darmstadt, Germany), 10 mM
EDTA and protease inhibitor cocktail set III (EMD Millipore, Darm-
stadt, Germany). Collagen VII complexes were immunoprecipitated
with the polyclonal a-NC2-10 antibody (Bruckner-Tuderman et al.,
1995) coupled to magnetic beads (Dynabeads, Invitrogen) at 4 1C for
3 hours. For separate IPs, eluates were combined after collagen VII
immunoaffinity purification, whereas lysates were combined before
the immunoaffinity purification for the combined IPs. Complexes
were washed three times with lysis buffer and once with 10 mM Tris
pH 7.6.The purified complexes were separated by SDS-PAGE, in-gel-
digested with trypsin, and the resulting peptides were analyzed by
tandem MS.
Additional materials and methods can be found online in the
Supplementary Information.
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